Chartwell Investment Partners, LLC Sage Therapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$26.15 - $77.24 $232,944 - $688,053	-8,908 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$60.18 - $154.77 $243,428 - $626,044	4,045 Added 83.18%	8,908 $643,000
Q3 2019 Oct 29, 2019	SELL	$140.29 - $189.96 $10,942 - $14,816	-78 Reduced 1.58%	4,863 $682,000
Q2 2019 Aug 19, 2019	SELL	$157.85 - $183.09 $2.67 Million - $3.1 Million	-16,934 Reduced 77.41%	4,941 $905,000
Q1 2019 Apr 11, 2019	BUY	$89.33 - $163.65 $34,302 - $62,841	384 Added 1.79%	21,875 $3.48 Million
Q4 2018 Feb 01, 2019	SELL	$81.94 - $139.71 $979,264 - $1.67 Million	-11,951 Reduced 35.74%	21,491 $2.06 Million
Q3 2018 Nov 08, 2018	BUY	$138.11 - $169.04 $1.17 Million - $1.44 Million	8,504 Added 34.1%	33,442 $4.72 Million
Q2 2018 Aug 09, 2018	SELL	$140.36 - $175.76 $542,491 - $679,312	-3,865 Reduced 13.42%	24,938 $3.9 Million
Q1 2018 May 08, 2018	BUY	$152.15 - $192.33 $56,295 - $71,162	370 Added 1.3%	28,803 $4.74 Million
Q1 2018 May 08, 2018	SELL	$152.15 - $192.33 $56,295 - $71,162	-370 Reduced 1.28%	28,433 $4.58 Million
Q4 2017 Feb 08, 2018	BUY	$60.72 - $167.34 $415,264 - $1.14 Million	6,839 Added 31.14%	28,803 $4.74 Million
Q3 2017 Nov 08, 2017	BUY	$61.4 - $88.52 $1.35 Million - $1.94 Million	21,964	21,964 $1.37 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $333M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.